We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
50.00 | 0.44% | 11,300.00 | 11,298.00 | 11,304.00 | 11,362.00 | 11,250.00 | 11,250.00 | 123,743 | 09:02:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 29.29 | 174.4B |
By Chip Cummins
LONDON -- The mystery surrounding the intentions of the chief executive of AstraZeneca PLC, one of the world's largest pharmaceutical firms, remains...a mystery.
Two days after an Israeli news report said Chief Executive Pascal Soriot had agreed to take the top job at a rival drug giant, Israel-based Teva Pharmaceutical Industries Ltd., AstraZeneca continues to say it won't comment, labeling that report -- and more recent reports that he is staying on -- as market rumors and speculation.
A spokesman late Friday said Dr. Soriot would host the presentation of the company's midyear financial results, expected later this month. But the spokesman declined to say whether that indicated Dr. Soriot was sticking around for the longer term.
A spokesman for Teva said it also wouldn't comment on market rumors.
Shares of AstraZeneca fell sharply Thursday, after an Israeli news site, Calcalist, reported the day before that Dr. Soriot had agreed to take the top job at Teva. They ended London trading down more than 3%. Despite the steep stock market drop, AstraZeneca has repeatedly stopped short of denying the report.
On Friday, shares finished lower for the second day running, falling another 0.29%, amid the uncertainty.
Write to Chip Cummins at chip.cummins@wsj.com
(END) Dow Jones Newswires
July 14, 2017 18:34 ET (22:34 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions